Christina is an advisor to early- and late-stage healthcare companies on go-to-market strategy, storytelling, and fundraising, and shares her insights via Second Opinion. Learn more at www.chrissyfarr.com
What happened to the digital health unicorns of 2020 to 2022?
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!